Jennifer Travers 💙 retweeted
Replying to @VFSGlobal
@VFSGlobal please can you help my daughter who is in your Edinburgh centre at the moment.
Having waited 6 weeks for an appointment yesterday, she was sent away having misunderstood the information. She has arrived back with you to complete her application, please assist her 🙏
Jennifer Travers 💙 retweeted
They say that, if you ask 3 myeloma experts the same question, you’ll get 5 different answers…
… finally, now, a question we can all agree on answer to: YES!
See you all in 🏴 for #IMS26 in September!
@szusmani @HiraSMian @Mohty_EBMT @UsuarezMD @EliasKarlMai @SurbhiSidanaMD
Jennifer Travers 💙 retweeted
A new era in AL staging - AL International Staging system (AL-ISS) - great presentation by @JahanzaibKhwaja and now published in @JCO_ASCO
Jennifer Travers 💙 retweeted
1/2 Many people living with myeloma experience symptoms for months or even years before receiving a diagnosis.
By sharing this post, you can help raise awareness and make sure more people recognise the warning signs sooner ⚠️ #MyelomaAwarenessWeek #MyelomaWarningSigns
Jennifer Travers 💙 retweeted
Honored to present tomorrow at EHA Milan!Gold Hall at 11 am Sunday June 15 All but one patient responded!Amaizing data which will be the experimental arm of an upcoming randomized study in ND NTE MM patients
Jennifer Travers 💙 retweeted
Replying to @DrRakeshPopat
@DrRakeshPopat flying the flag for the UK Myeloma community with a presentation of very impressive results with the use of trispecific antibody JNJ-5322 in the Plenary session at #EHA2025
Jennifer Travers 💙 retweeted
Kwee Yong from @uclcancer making the case we need to understand the biology of smouldering myeloma better to pick the right intervention. #EHA2025
Jennifer Travers 💙 retweeted
@EHA plenary session - @DrRakeshPopat presenting JNJ-5322 - a trispecific antibody in relapse refractory myeloma. A new potential step change for RR MM
Jennifer Travers 💙 retweeted
Reminder to @BOPACommittee, @APTUK1 and @UKONSmember …6 days to IMS abstract deadline …. A fantastic opportunity to showcase your amazing work 💥💥
⏳6 days to abstract deadline @Myeloma_Society 🤔submitting to ‘Yay-NAH’ #IMS2025 events.jspargo.com/ims25/CUS…
Jennifer Travers 💙 retweeted
Looking forward to speaking on treatment of High-risk #myeloma at @EHA_Hematology conference in Milano in June - many thanks @Myeloma_Society and EHA for invite. In the meantime, hope people might enjoy our @BritSocHaem podcast on this topic:
podbean.com/ew/pb-2734e-17fd…
Jennifer Travers 💙 retweeted
Another important contribution to the debate on limiting lenalidomide maintenance post-ASCT.
Sustained bone marrow and imaging MRD negativity for 3 years drives discontinuation of maintenance post-ASCT in myeloma ashpublications.org/blood/ar…
Jennifer Travers 💙 retweeted
A opportunity to join our research team - Haematology trainees interested in plasma cell disorders - DM if interested @UKMyelomaSoc @BritSocHaem @ASH_hematology
Jennifer Travers 💙 retweeted
Solitary plasmacytoma.
One lesion, but 3 possible entities with differing prognosis in the differential diagnosis.
Outcomes and management. @MayoMyeloma @BloodAdvances @ASH_hematology ashpublications.org/bloodadv…
Jennifer Travers 💙 retweeted
REGISTRATION IS OPEN FOR #ESHMM2026
March 26-28, 2026 / Stockholm, Sweden
8th Translational Research Conference
Multiple Myeloma
Chairs : Hartmut Goldschmidt, @MyMKaiser, @SLentzsch
To register & for more information 👉bit.ly/4cy6PCW
#ESHCONFERENCES #MMsm #HAEMATOLOGY
Jennifer Travers 💙 retweeted
There is a real urgency to get it right for older adults across health & social care.
These resources based on Ageing & Frailty standards enable that improvement journey.
We need to work as a focused & integrated teams to deliver this around Scotland
#frailty
Jennifer Travers 💙 retweeted
The inaugural meeting of @irishmyelomasoc will take place September 12th in Dublin. Open to HCPs/trainees working with myeloma patients, a wonderful panel of speakers promises to make this a great meeting 🇮🇪 #mmsm
Jennifer Travers 💙 retweeted
Blood Cancer UK investing in exciting research over next 5 years, says chief exec Helen Rowntree. Such encouraging news, Helen! #HPCC25 @bloodcancer_uk
Jennifer Travers 💙 retweeted
Excellent session on frailty and myeloma @BritSocHaem. Inspiring, entertaining and practice changing talks delivered by @profBigG @Anniemcmillan10 and Salomon Mainer from IFM.
Take home message: stop Dex early! #downwithdex #mmsm








































